Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)

Hong Kong · Delayed Price · Currency is HKD

41.58

-1.08 (-2.53%)

At close: Mar 4, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Medical Products	277.90M	232.34M	183.03M	90.09M	14.56M
Medical Products Growth	19.61%	26.94%	103.17%	518.66%	-
Total	277.90M	232.34M	183.03M	90.09M	14.56M
Total Growth	19.61%	26.94%	103.17%	518.66%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Mainland China	269.50M	231.27M	182.91M	90.06M	14.56M
Mainland China Growth	16.53%	26.44%	103.09%	518.47%	-
Others	8.40M	1.07M	123.00K	27.00K	-
Others Growth	683.85%	770.73%	355.56%	-	-
Total	277.90M	232.34M	183.03M	90.09M	14.56M
Total Growth	19.61%	26.94%	103.17%	518.66%	-

Source: S&P Global Market Intelligence.